Literature DB >> 11432752

Inactivation of Aeromonas hydrophila metallo-beta-lactamase by cephamycins and moxalactam.

A Zervosen1, M H Valladares, B Devreese, C Prosperi-Meys, H W Adolph, P S Mercuri, M Vanhove, G Amicosante, J van Beeumen, J M Frère, M Galleni.   

Abstract

Incubation of moxalactam and cefoxitin with the Aeromonas hydrophila metallo-beta-lactamase CphA leads to enzyme-catalyzed hydrolysis of both compounds and to irreversible inactivation of the enzyme by the reaction products. As shown by electrospray mass spectrometry, the inactivation of CphA by cefoxitin and moxalactam is accompanied by the formation of stable adducts with mass increases of 445 and 111 Da, respectively. The single thiol group of the inactivated enzyme is no longer titrable, and dithiothreitol treatment of the complexes partially restores the catalytic activity. The mechanism of inactivation by moxalactam was studied in detail. Hydrolysis of moxalactam is followed by elimination of the 3' leaving group (5-mercapto-1-methyltetrazole), which forms a disulfide bond with the cysteine residue of CphA located in the active site. Interestingly, this reaction is catalyzed by cacodylate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432752     DOI: 10.1046/j.1432-1327.2001.02298.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Docking and scoring of metallo-beta-lactamases inhibitors.

Authors:  Lars Olsen; Ingrid Pettersson; Lars Hemmingsen; Hans-Werner Adolph; Flemming Steen Jørgensen
Journal:  J Comput Aided Mol Des       Date:  2004-04       Impact factor: 3.686

2.  Biochemical characterization of Sfh-I, a subclass B2 metallo-beta-lactamase from Serratia fonticola UTAD54.

Authors:  Fátima Fonseca; Christopher J Arthur; Elizabeth H C Bromley; Bart Samyn; Pablo Moerman; Maria José Saavedra; António Correia; James Spencer
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

3.  Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.

Authors:  L E Horsfall; G Garau; B M R Liénard; O Dideberg; C J Schofield; J M Frère; M Galleni
Journal:  Antimicrob Agents Chemother       Date:  2007-02-16       Impact factor: 5.191

4.  An altered zinc-binding site confers resistance to a covalent inactivator of New Delhi metallo-beta-lactamase-1 (NDM-1) discovered by high-throughput screening.

Authors:  Pei W Thomas; Timothy Spicer; Michael Cammarata; Jennifer S Brodbelt; Peter Hodder; Walter Fast
Journal:  Bioorg Med Chem       Date:  2013-03-29       Impact factor: 3.641

Review 5.  Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.

Authors:  Anou M Somboro; John Osei Sekyere; Daniel G Amoako; Sabiha Y Essack; Linda A Bester
Journal:  Appl Environ Microbiol       Date:  2018-08-31       Impact factor: 4.792

Review 6.  Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.

Authors:  Antonella R Palacios; María-Agustina Rossi; Graciela S Mahler; Alejandro J Vila
Journal:  Biomolecules       Date:  2020-06-03

7.  Assay platform for clinically relevant metallo-β-lactamases.

Authors:  Sander S van Berkel; Jürgen Brem; Anna M Rydzik; Ramya Salimraj; Ricky Cain; Anil Verma; Raymond J Owens; Colin W G Fishwick; James Spencer; Christopher J Schofield
Journal:  J Med Chem       Date:  2013-08-16       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.